Pharma & Biopharma

The Application Book 2022 summarizes recent application notes across a range of exciting topics

Geneticist Eric Chow describes how genomic surveillance can identify emerging SARS-CoV-2 variants of concern

How KNAUERs new pump and liquid handler help bridge the gap between classic HPLC systems and the demand for fast, reproducible high-resolution methods

How can new LC-MS system help biopharma manufacturers?

Sagi Nahum and Dana Fuchs Telem from Orgenesis talk us through the central challenges – and solutions – in the analysis of cell and gene therapies

Geoff Winkett discusses developments in molecular spectroscopy and the growth of the biopharma market

We share some of the pieces we’ve published in the (Bio)pharma space so far this year

Merck joins forces with Agilent Technologies to develop process analytical technologies for downstream bioprocess monitoring and control

What would it mean for science as a whole if the results of a seminal Alzheimer's paper underpinning the amyloid hypothesis were fabricated?

Putting COVID-19 on a diet, native ambient MS aids drug discovery, and elucidating monoclonal antibody structure with IMS-MS…